Corcept Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. 

CEO
Joseph K. Belanoff
CEOJoseph K. Belanoff
Employees
730
Employees730
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1998
Founded1998
Employees
730
Employees730

CORT Key Statistics

Market cap
12.31B
Market cap12.31B
Price-Earnings ratio
271.98
Price-Earnings ratio271.98
Dividend yield
Dividend yield
Average volume
818.47K
Average volume818.47K
High today
$120.64
High today$120.64
Low today
$112.98
Low today$112.98
Open price
$117.02
Open price$117.02
Volume
858.09K
Volume858.09K
52 Week high
$126.38
52 Week high$126.38
52 Week low
$28.66
52 Week low$28.66

Stock Snapshot

As of today, Corcept Therapeutics(CORT) shares are valued at $113.88. The company's market cap stands at 12.31B, with a P/E ratio of 271.98.

As of 2026-08-29, Corcept Therapeutics(CORT) stock has fluctuated between $112.98 and $120.64. The current price stands at $113.88, placing the stock +0.8% above today's low and -5.6% off the high.

Corcept Therapeutics(CORT) shares are trading with a volume of 858.09K, against a daily average of 818.47K.

During the past year, Corcept Therapeutics(CORT) stock moved between $28.66 at its lowest and $126.38 at its peak.

During the past year, Corcept Therapeutics(CORT) stock moved between $28.66 at its lowest and $126.38 at its peak.

CORT News

TipRanks 22h
Corcept Therapeutics Insider Makes Major Multimillion-Dollar Stock Move

New insider activity at Corcept Therapeutics ( (CORT) ) has taken place on August 28, 2026. Director Park Kimberly has recently cashed out a significant portion...

Simply Wall St 2d
Is Corcept’s Earnings Beat And Pipeline Optimism Altering The Investment Case For Corcept Therapeutics?

In recent months, Corcept Therapeutics reported earnings that exceeded analyst expectations, reinforcing interest in its portfolio of treatments targeting sever...

Is Corcept’s Earnings Beat And Pipeline Optimism Altering The Investment Case For Corcept Therapeutics?

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
14.3%
Sell
14.3%

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.